Publications by authors named "Cosimo Rasola"

Claim this Profile
N
New developments and standard of care in the management of advanced gastric cancer.
Léonard Depotte, Juliette Palle, Cosimo Rasola, Chloé Broudin, Vlad-Adrian Afrăsânie

Clin Res Hepatol Gastroenterol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.
Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro, Daniele Rossini, Vincenzo Formica

J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.
Cosimo Rasola, Pierre Laurent-Puig, Thierry André, Antoine Falcoz, Come Lepage

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.
Alessandra A Prete, Paolo Manca, Marco Messina, Vincenzo Formica, Giovanni L Frassineti, Cosimo Rasola

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer.
Letizia Procaccio, Francesca Bergamo, Maura Gatti, Benedetta Chiusole, Giuseppina Tierno, Cosimo Rasola

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
Roberto Moretto, Andrew Elliott, Daniele Rossini, Rossana Intini, Veronica Conca, Cosimo Rasola

Br J Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
Sara Lonardi, Halla Nimeiri, Chang Xu, Daniel R Zollinger, Russell W Madison, Cosimo Rasola

Int J Mol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches.
Carlotta Ceccon, Valentina Angerilli, Cosimo Rasola, Letizia Procaccio, Marianna Sabbadin

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative Ultraselection of Patients With / Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy.
Giovanni Randon, Giulia Maddalena, Marco Maria Germani, Chiara Carlotta Pircher, Paolo Manca, Cosimo Rasola

JCO Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer.
Alessandra Anna Prete, Letizia Procaccio, Francesca Bergamo, Cosimo Rasola, Floriana Nappo

Curr Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study.
Letizia Procaccio, Francesca Bergamo, Francesca Daniel, Cosimo Rasola, Giada Munari

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Roberto Moretto, Daniele Rossini, Veronica Conca, Sara Lonardi, Cosimo Rasola

Br J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases.
Fotios Loupakis, Shruti Sharma, Madiha Derouazi, Sabina Murgioni, Paola Biason, Cosimo Rasola

JCO Precis Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterotopic Implantation of Decellularized Pulmonary Artery Homografts In A Rodent Model: Technique Description and Preliminary Report.
Arben Dedja, Massimo A Padalino, Mila Della Barbera, Cosimo Rasola, Paola Pesce

J Invest Surg· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis